Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test
Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgM
Testing Method Category
Mixed
Testing Method
RDT kit (Augurix SARS-CoV-2 IgM/IgG); in-house rFIA; ELISA kit (Euroimmun SARS-CoV-2 IgG)
Testing Method - Additional Info
Augurix performance is assessed vs in house rFIA and ELISA kit
Reported Performance
sensitivity: 88% (RDT), specificity: 98% (RDT), PPV: 97% (RDT), NPV: 94% (RDT)
Sample Size
91 patients
Assay Type
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements